Agilent ICP-MS Journal (August 2011 – Issue 47)

Significance of the Topic

Elemental speciation and trace‐element profiling by ICP‐MS are critical for ensuring nutritional efficacy, pharmaceutical safety, and environmental monitoring. Selenium speciation in enriched yeasts validates supplement quality and bioavailability. Advanced ICP‐MS methods support new pharmacopeial requirements for elemental impurities in drug products. Rapid, low‐level detection of long‐lived radionuclides such as 129I enhances environmental and food safety assessment. Efficient instrument manufacturing and user training ensure consistent analytical capacity.

Objectives and Overview

The Journal Issue presents four key studies:

• Selenium speciation in Se‐enriched yeast by LC‐ICP‐MS with mass balance calculations.
• Determination of metal impurities in pharmaceutical ingredients in anticipation of new USP <232>/<233> guidelines.
• Monitoring ultra‐traces of radioactive iodine‐129 using ICP‐MS with oxygen reaction mode.
• Recovery of ICP‐MS manufacturing following the 2011 Japanese earthquake and training initiatives.

Methodology and Instrumentation

Core analytical techniques centered on the Agilent 7700x ICP‐MS, featuring:

• Octopole Reaction System (ORS3) with helium mode for polyatomic interference removal in metallic analytes.
• Oxygen reaction mode for elimination of 129Xe overlap on 129I.
• High Matrix Introduction (HMI) for robust plasma performance at elevated dissolved solids.

Se speciation employed an Agilent 1260 LC with Zorbax C8 column and Tris buffer extraction of yeast fractions. Pharmaceutical impurity analysis used 2% HNO3/0.5% HCl sample digestion and validated spiking at 0.5J–1.5J levels under KED mode.

Main Results and Discussion

Se speciation recovered 89–97% of total Se in soluble enzymatic extracts, with selenomethionine comprising ~66% of soluble Se and mass balance recoveries >96% via compound‐independent calibration. Pharmaceutical analysis achieved 92–119% spike recoveries and <3% RSD for all 16 regulated elements, meeting USP <233> validation criteria. Radioiodine monitoring delivered detection limits <2 ng/L and precise 129I/127I ratios (<2% RSD). Post‐earthquake, ICP‐MS output returned to full capacity within two months, supported by supply‐chain resilience and active customer training in India.

Benefits and Practical Applications

These methods enable:

• Regulatory compliance with stringent pharmacopeial limits on elemental impurities.
• Rapid, high‐throughput screening of nutritional supplements and feeds.
• Fast, low‐level radionuclide surveillance in environmental and food matrices.
• Consistent instrument supply, maintenance, and user competence through dedicated manufacturing and training.

Future Trends and Potential Uses

• Expanded speciation workflows coupling HPLC and ICP‐MS for diverse trace elements in complex matrices.
• Adoption of reaction mode ICP‐MS for next‐generation pharmacopeial chapters on catalysts and impurities.
• Integration of high‐throughput environmental monitoring networks for radionuclides.
• Enhanced automation and data workflows to streamline compliance testing.

Conclusion

Agilent’s LC‐ICP‐MS and 7700x ICP‐MS platforms deliver robust, sensitive, and precise solutions for elemental speciation, pharmaceutical impurity analysis, and environmental radionuclide monitoring. Combined with manufacturing resilience and targeted user training, these technologies support evolving regulatory and research demands.

Reference

• 1. K. A. Jacques, Feed Compounder 2002, 14-21.
• 2. H. Goenaga-Infante et al., Journal of Analytical Atomic Spectrometry 2005, 20, 864-870.